Ballistic Strength Training in Stroke: A Pilot Study

October 17, 2016 updated by: Ms. Rowan Frew, Bayside Health

Ballistic Strength Training in Stroke: A Phase II Randomized, Controlled, Assessor Blinded Pilot Study

This pilot study intends to evaluate whether stroke patients can complete ballistic strength exercises for thirty minutes, three times per week over a six week training period in addition to their existing rehabilitation program.

It will evaluate whether using ballistic training principles, is superior in improving mobility compared with usual care exercises to improve mobility and leg strength in stroke patients.

In this study there will be 15 participants per group, a total of 30 participants. The control group will receive usual care consistent with existing rehabilitation practice and literature. The experimental group will perform task specific strength training in a ballistic fashion.

Study Overview

Status

Completed

Conditions

Detailed Description

Research Aims:

  1. To establish the feasibility of ballistic strength training in stroke and
  2. To evaluate the effects of ballistic strength training exercises on mobility outcomes, strength and quality of life when compared with usual care.

Methods:

This wil be a prospective, randomized, controlled, assessor-blinded pilot study. It will be conducted 3 x per week for 6 weeks (i.e. a total of 18 sessions lasting 30 minutes).

Primary outcome measure: Feasibility

  • Recruitment
  • Retention/Attrition
  • Clinical Feasibility
  • Safety

Secondary outcome measures - measured at baseline and completion

  • Ten metre walk test (10MWT) comfortable pace
  • 10MWT maximum safe pace
  • High level mobility assessment tool (HiMAT): Only in participants where 10MWT is <12.5s at baseline
  • Timed up and go test (TUG)
  • Functional Ambulation Category (FAC)
  • Health Related Quality of Life (HRQoL) via AQoL-4D

Description of intervention:

Control Group:

The control group will complete a suite of exercises based upon existing rehabilitation practices that aim to improve mobility after stroke. The supervising physiotherapist will select and progress the exercises, recording the performance of exercises in an exercise log and detailing incidence of adverse events. Exercise selection will include: gait retraining, cardiovascular fitness, lower limb strengthening, static and dynamic balance

Experimental group:

The experimental group will complete jump squats on the leg sled, single leg toe push offs (or bilateral where unable to complete single), alternating legs (i.e. bounding), mini tramp jumping, progressing to jogging, quick hip flexion and bounding on land.

Study Type

Interventional

Enrollment (Actual)

31

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Victoria
      • Melbourne, Victoria, Australia, 3162
        • Alfred Health - Caulfield Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Inpatient at Caulfield Hospital Neurological Rehabilitation Unit at the time of recruitment
  • Diagnosis of first stroke
  • Presence of lower limb weakness determined by >10% difference in knee extensor strength between sides
  • Functional Ambulation Category (FAC) > 3
  • Can walk a minimal distance of 14 metres (to allow measurement on a 10metre walk test (10MWT)

Participants who meet all the inclusion criteria except for their FAC score will have their FAC score re-measured on a weekly basis until they reach a score of greater than or equal to 3, at which point they become eligible and will be approached for recruitment.

Exclusion Criteria:

  • Unable to provide informed consent (determined by consultation with rehabilitation consultant and the team neuropsychologist)
  • Other diagnosed central nervous system disorder affecting mobility
  • Active oncological diagnosis
  • Unstable medication condition such as unstable diabetes or unstable cardiac condition that would prevent participation in cardiovascular activity
  • Recent orthopaedic trauma and/or osteoarthritis that would limit participation in physical exercise
  • Not willing to continue to attend the program if they discharge home before the end of the six week program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Experimental
Ballistic Strength Training
The experimental group will complete jump squats on the leg sled, single leg toe push offs (or bilateral where unable to complete single), alternating legs (i.e. bounding), mini tramp jumping, progressing to jogging, quick hip flexion and bounding on land.
ACTIVE_COMPARATOR: Control
Usual care Physiotherapy
This group will complete a suite of exercises based upon existing rehabilitation practices that aim to improve mobility after stroke. The supervising physiotherapist will select and progress the exercises, recording the performance of exercises in an exercise log and detailing incidence of adverse events. Exercise selection will include: gait retraining, cardiovascular fitness, lower limb strengthening, static and dynamic balance.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility
Time Frame: 6 weeks

Recruitment:

  • Number of stroke admissions to Caulfield Hospital
  • Number of stroke admissions that meet the inclusion/exclusion criteria
  • Number of those eligible who consent to participate

Retention/Attrition:

  • Drop out rates over the six week period and reasons for drop outs
  • Number of sessions attended out of 18 over the six week period

Clinical feasibility

  • Capacity of participants to perform the required exercises
  • Level of assistance required by therapist to perform the exercises - i.e. independent, supervision, assisted
  • Barriers to completing the required exercises during a session, i.e. incidence of delayed onset muscle soreness, fatigue
  • To be recorded for every session

Safety

  • Incidence of adverse events
  • Types of adverse events
  • To be recorded for every session
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
10 metre walk test comfortable pace
Time Frame: Baseline and 6 weeks
Participants will be measured at comfortable gait speed. The middle 10metres of a 14 metre track will be recorded. The participant will be asked to walk at their own comfortable speed. There will be a cone at the start and finish of the 14metre track to guide participants and the middle 10 metres will be recorded.
Baseline and 6 weeks
10 metre walk test, maximum safe pace
Time Frame: Baseline and 6 weeks
Same set-up as 10MWT comfortable pace, however the participant will be asked to walk as fast as they safely can without breaking into a run.
Baseline and 6 weeks
High level mobility assessment tool (HiMAT)
Time Frame: Baseline and 6 weeks
The HiMAT is a 13 item assessment tool designed to assess high level walking tasks, the ability to negotiate stairs and the ability to run, hop, skip and jump. The HiMAT will be used to evaluate performance for higher level participants in the study where their 10MWT result may have a ceiling effect (where participants complete 10MWT in under 12.5seconds).
Baseline and 6 weeks
Timed up and go test (TUG)
Time Frame: Baseline and 6 weeks
The TUG is highly reliable in stroke populations and correlates with walking performance and incidence of falls. Participants will be measured on the TUG from a 45cm chair. The will be asked to complete the test at their own comfortable speed.
Baseline and 6 weeks
Functional Ambulation Category (FAC)
Time Frame: Baseline and 6 weeks
The FAC is a simple tool which uses an ordinal scale of 1 to 6 to measure the level of assistance a person requires to walk, and the different types of terrain they can manage such as indoors vs. outdoors, slopes and inclines.
Baseline and 6 weeks
Assessment of quality of life 4D
Time Frame: Baseline and 6 weeks
Health related quality of Life will be measured using the Assessment of quality of life 4D. This has been shown to be a valid and sensitive measure in stroke, and has been used to determine the effects of mobility on HRQoL in neurological populations.
Baseline and 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Genevieve C Hendrey, B Phys (Hons), The Alfred
  • Principal Investigator: Anne E Holland, PhD, Alfred Health and La Trobe University
  • Principal Investigator: Gavin Williams, PhD, Epworth Healthcare, Melbourne University, La Trobe University
  • Principal Investigator: Ross Clark, PhD, Australian Catholic University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2014

Primary Completion (ACTUAL)

September 1, 2016

Study Completion (ACTUAL)

September 1, 2016

Study Registration Dates

First Submitted

October 7, 2013

First Submitted That Met QC Criteria

October 8, 2013

First Posted (ESTIMATE)

October 9, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

October 19, 2016

Last Update Submitted That Met QC Criteria

October 17, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Ballistic Strength Training

3
Subscribe